85 related articles for article (PubMed ID: 25693786)
1. Bis-3-chloropiperidines containing bridging lysine linkers: Influence of side chain structure on DNA alkylating activity.
Zuravka I; Roesmann R; Sosic A; Göttlich R; Gatto B
Bioorg Med Chem; 2015 Mar; 23(6):1241-50. PubMed ID: 25693786
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and DNA cleavage activity of Bis-3-chloropiperidines as alkylating agents.
Zuravka I; Roesmann R; Sosic A; Wende W; Pingoud A; Gatto B; Göttlich R
ChemMedChem; 2014 Sep; 9(9):2178-85. PubMed ID: 24616300
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a bis-3-chloropiperidine derivative incorporating an anthraquinone pharmacophore.
Zuravka I; Sosic A; Gatto B; Göttlich R
Bioorg Med Chem Lett; 2015 Oct; 25(20):4606-9. PubMed ID: 26342869
[TBL] [Abstract][Full Text] [Related]
4. Aromatic Linkers Unleash the Antiproliferative Potential of 3-Chloropiperidines Against Pancreatic Cancer Cells.
Helbing T; Carraro C; Francke A; Sosic A; De Franco M; Gandin V; Göttlich R; Gatto B
ChemMedChem; 2020 Nov; 15(21):2040-2051. PubMed ID: 32744774
[TBL] [Abstract][Full Text] [Related]
5. Appended Aromatic Moieties in Flexible Bis-3-chloropiperidines Confer Tropism against Pancreatic Cancer Cells.
Carraro C; Helbing T; Francke A; Zuravka I; Sosic A; De Franco M; Gandin V; Gatto B; Göttlich DR
ChemMedChem; 2021 Mar; 16(5):860-868. PubMed ID: 33200541
[TBL] [Abstract][Full Text] [Related]
6. Direct and Topoisomerase II Mediated DNA Damage by Bis-3-chloropiperidines: The Importance of Being an Earnest G.
Sosic A; Zuravka I; Schmitt NK; Miola A; Göttlich R; Fabris D; Gatto B
ChemMedChem; 2017 Sep; 12(17):1471-1479. PubMed ID: 28724198
[TBL] [Abstract][Full Text] [Related]
7. Secondary 3-Chloropiperidines: Powerful Alkylating Agents.
Georg M; Laping LA; Billo V; Gatto B; Friedhoff P; Göttlich R
ChemistryOpen; 2024 Jun; 13(6):e202300181. PubMed ID: 38088585
[TBL] [Abstract][Full Text] [Related]
8. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
Cloutier JF; Castonguay A; O'Connor TR; Drouin R
J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
Anderson FM; O'Hare CC; Hartley JA; Robins DJ
Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel caged DNA alkylating agents bearing 3,4-epoxypiperidine structure.
Kawada Y; Kodama T; Miyashita K; Imanishi T; Obika S
Org Biomol Chem; 2012 Jul; 10(26):5102-8. PubMed ID: 22614066
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
12. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles.
Parker LL; Anderson FM; O'Hare CC; Lacy SM; Bingham JP; Robins DJ; Hartley JA
Bioorg Med Chem; 2005 Apr; 13(7):2389-95. PubMed ID: 15755641
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of guanine alkylation by nitrogen mustards: a computational study.
Polavarapu A; Stillabower JA; Stubblefield SG; Taylor WM; Baik MH
J Org Chem; 2012 Jul; 77(14):5914-21. PubMed ID: 22681226
[TBL] [Abstract][Full Text] [Related]
15. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
16. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
17. Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking.
Chen W; Han Y; Peng X
Chemistry; 2014 Jun; 20(24):7410-8. PubMed ID: 24806710
[TBL] [Abstract][Full Text] [Related]
18. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
19. Use of [8-3H]guanine-labeled deoxyribonucleic acid to study alkylating agent reaction kinetics and stability.
Mattes WB
Anal Biochem; 1992 Oct; 206(1):161-7. PubMed ID: 1280918
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.
Henderson ND; Lacy SM; O'Hare CC; Hartley JA; McClean S; Wakelin LP; Kelland LR; Robins DJ
Anticancer Drug Des; 1998 Oct; 13(7):749-68. PubMed ID: 9807160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
